Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Abt-301
Colorectal Cancer
Anbogen Therapeutics, Inc.
P1/2
CC
(47)
Acetazolamide
Schizoaffective Disorder
Vishwajit Nimgaonkar, MD PhD
P1/2
CC
(47)
Aclarubicin
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Shanghai Jiao Tong University School of Medicine
P1/2
CC
(47)
Adg 106
Non-Small Cell Lung Carcinoma
National University Hospital, Singapore
P1/2
CC
(47)
Aguix
Pancreatic Adenocarcinoma
Dana-Farber Cancer Institute
P1/2
CC
(47)
Aguix
Malignant Pancreatic Neoplasm
Dana-Farber Cancer Institute
P1/2
CC
(47)
ak129
Head And Neck Squamous Cell Carcinoma
Akeso
P1/2
CC
(47)
Ale.P02
Cervical Squamous Cell Carcinoma
Alentis Therapeutics AG
P1/2
CC
(47)
Ale.P03
Cervical Squamous Cell Carcinoma
Alentis Therapeutics AG
P1/2
CC
(47)
Ale.P03
Intrahepatic Cholangiocarcinoma
Alentis Therapeutics AG
P1/2
CC
(47)
Aleta-001
Follicular Lymphoma
Cancer Research UK
P1/2
CC
(47)
Aleta-001
Mantle Cell Lymphoma
Cancer Research UK
P1/2
CC
(47)
Alintegimod
Malignant Pleural Mesothelioma
7 Hills Pharma, LLC
P1/2
CC
(47)
Allocetra-Ots
Peritoneal Carcinomatosis
Enlivex Therapeutics RDO Ltd.
P1/2
CC
(47)
Allogeneic Cd19-Star T Cell
B-Cell Non-Hodgkin Lymphoma
Chinese PLA General Hospital
P1/2
CC
(47)
Allogenic Cd19-Car-Γδt Cell
B-Cell Non-Hodgkin Lymphoma
Chinese PLA General Hospital
P1/2
CC
(47)
Aln-4324
Type 2 Diabetes Mellitus
Alnylam Pharmaceuticals
P1/2
CC
(47)
Aln-Cideb
Metabolic Dysfunction-Associated Steatotic Liver Disease
Regeneron Pharmaceuticals
P1/2
CC
(47)
Aln-Khk
Type 2 Diabetes Mellitus
Alnylam Pharmaceuticals
P1/2
CC
(47)
Alnugranogene Aldeparvovec
Frontotemporal Dementia
Passage Bio, Inc.
P1/2
CC
(47)
Alpha Tocopherol
Uterine Cancer
University of Nebraska
P1/2
CC
(47)
Amt-191
Fabry Disease
UniQure Biopharma B.V.
P1/2
CC
(47)
Amxt1501
Cancer
Aminex Therapeutics, Inc.
P1/2
CC
(47)
Amxt1501
Ovarian Cancer
Aminex Therapeutics, Inc.
P1/2
CC
(47)
Amxt 1501 Dicaprate
Hormone Receptor-Positive Breast Cancer
Aminex Therapeutics, Inc.
P1/2
CC
(47)
Showing 2101 to 2125 of 6,308 assets
Previous
Page 85 of 253
Next